Eli Lilly Attys Win £400K Costs In Genentech IP Fight

Law360, London (March 13, 2020, 7:28 PM GMT) -- A judge Friday awarded Eli Lilly and Company £400,000 ($485,000) in attorney fees for its largely successful efforts so far to revoke Genentech Inc.’s patent for a psoriasis treatment, which followed a fight between the rivals on a similar patent that racked up about £11 million in costs.

In his ruling, Deputy High Court Judge Roger Wyand ordered Genentech to pay half of the costs Eli Lilly incurred in pursuing a trial on a preliminary issue — whether Genentech could pursue claims on a patent similar to one revoked in the prior action — along with a request for summary judgment...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!